Product Images Deferasirox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Deferasirox NDC 59651-410 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

fig1 - deferasirox fig1

fig1 - deferasirox fig1

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 90 mg (30 Tablet Bottle) - deferasirox fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 90 mg (30 Tablet Bottle) - deferasirox fig2

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 180 mg (30 Tablet Bottle) - deferasirox fig3

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 180 mg (30 Tablet Bottle) - deferasirox fig3

Deferasirox Tablets are available in a pack of 30 tablets, each containing 180 mg of Deferasirox. The usual dosage should be followed as mentioned in the package insert. It is important to keep this medication and all drugs out of the reach of children. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and protected from moisture. A Medication Guide should be printed for each patient, which can be found at www.aurobindousa.com/medication-guides. The tablets are distributed by Aurobindo Pharma USA, Inc. and manufactured in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 360 mg (30 Tablet Bottle) - deferasirox fig4

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 360 mg (30 Tablet Bottle) - deferasirox fig4

CHEMICAL STRUCTURE - deferasirox str

CHEMICAL STRUCTURE - deferasirox str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.